Tina Howden

Title: Tina Howden: Innovator in Ophthalmic and Adipose Tissue Research

Introduction

Tina Howden is a prominent inventor based in Singapore, known for her innovative contributions to the fields of ophthalmic compositions and adipose tissue management. With a total of 3 patents, her work has significantly impacted medical treatments and formulations.

Latest Patents

One of her latest patents is titled "Liposomal formulations of corticosteroids and uses thereof." This patent provides ophthalmic compositions that include a steroid, such as prednisolone, encapsulated in a liposomal carrier, along with methods of use. Another notable patent is "Methods and compositions for reducing adipocyte numbers." This invention outlines a method for reducing subcutaneous and visceral fat deposits in vivo by using a composition of latanoprost encapsulated in a liposome made solely of egg phosphatidylcholine (EggPC) or palmitoyloleoyl phosphatidylcholine (POPC). The patent also discusses methods for treating conditions associated with excess upper airway fat.

Career Highlights

Tina has worked with esteemed organizations such as Nanyang Technological University and Singapore Health Services Pte Ltd. Her experience in these institutions has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.

Collaborations

Throughout her career, Tina has collaborated with notable colleagues, including Subramanian Venkatraman and Jayaganesh V Natarajan. These partnerships have fostered a collaborative environment that enhances the development of her inventions.

Conclusion

Tina Howden's contributions to innovation in ophthalmic and adipose tissue research highlight her role as a leading inventor in her field. Her patents reflect her commitment to advancing medical science and improving patient care.